DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹8.00 Cr | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr |
What is the latest Contingent Liabilities ratio of DIVIS LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹8.00 Cr |
| Mar2025 | ₹8.00 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹89 Cr |
| Mar2022 | ₹89 Cr |
How is Contingent Liabilities of DIVIS LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.00 Cr | 0.00 | |
| Mar2025 | ₹8.00 Cr | -96.89 | |
| Mar2024 | ₹257 Cr | 188.76 | |
| Mar2023 | ₹89 Cr | -0.03 | |
| Mar2022 | ₹89 Cr | - | |
Compare Contingent Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹220,140.7 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| MANKIND PHARMA | ₹100,395.0 Cr | -1.6% | -2.3% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 2.9% |
22.7% |
25.5% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses